Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Mol Endocrinol. 2001 Jun;15(6):946-59. doi: 10.1210/mend.15.6.0664.
Mol Endocrinol. 2001.
PMID: 11376113